Clinical Trials of Venetoclax in Myeloma Stopped Due to Deaths Clinical Trials of Venetoclax in Myeloma Stopped Due to Deaths

The FDA issued a partial hold on all ongoing clinical trials evaluating venetoclax in multiple myeloma because of an excessive number of deaths seen in the BELLINI study.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news